Browse our Editorials

Research in many different areas of medicine will benefit from new approaches to peer review and publishing.

eLife is publishing a special issue on aging, geroscience and longevity to mark the rapid progress made in this field over the past decade, both in terms of mechanistic understanding and translational approaches that are poised to have clinical impact on age-related diseases.

From July 2021 eLife will only review manuscripts already published as preprints, and will focus its editorial process on producing public reviews to be posted alongside the preprints.

​​ The eLife Early-Career Advisory Group calls for radical changes at eLife and other journals to make science more diverse and inclusive.

eLife, like the rest of science, must tackle the many inequalities experienced by Black scientists.

eLife is making changes to its policies on peer review in response to the impact of COVID-19 on the scientific community.

As he prepares to step down as the Editor-in-Chief of eLife, Randy Schekman reflects on the origins of the journal, the eLife approach to peer review, and current challenges in scientific publishing.

eLife is conducting a trial in which authors will decide how to respond to the issues raised during peer review.

Journals can benefit from listening to graduate students, postdocs and newly-independent group leaders.

Five years after eLife published its first papers, we reflect on our consultative approach to peer review, the challenges of reproducibility, and the need to reform how published research is assessed.